Gastrointestinal conditions

Journal of the American College of Surgeons

Volumn 190, Issue 2, 2000, Pages 134-151

  Bell Jr , Richard H ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Box 358280 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CHOLECYSTITIS; APPENDICITIS; BARRETT ESOPHAGUS; BILE DUCT CANCER; CHOLECYSTECTOMY; COMMON BILE DUCT STONE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SURGERY; HUMAN; INGUINAL HERNIA; LAPAROSCOPIC SURGERY; LIVER CANCER; LIVER TRANSPLANTATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PANCREAS CANCER; PANCREATITIS; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE OBSTRUCTION; STOMACH CANCER; SURGICAL TECHNIQUE; ULCER PERFORATION; ZOLLINGER ELLISON SYNDROME;

EID: 0343986534     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(99)00250-1     Document Type: Article

References (92)

1. Lundell L, Miettinen P, Myrvold HE, et al. A randomized comparison between omeprazole and open antireflux surgery in the management of chronic gastroesophageal reflux disease: report on the five-year follow-up. Presented at the 85th Clinical Congress, American College of Surgeons, San Francisco, CA, October 10-15, 1999.
2. Trus TL, Laycock WS, Waring JP, et al. Improvement in quality of life measures after laparoscopic antireflux surgery. Ann Surg 1999;229:331-336.
3. Spivak H, Smith CD, Phichith A, et al. Asthma and gastroesophageal reflux: fundoplication decreases need for systemic corticosteroids. J Gastrointest Surg 1999;3:477-482.
4. Spivak H, Farrell TM, Trus TL, et al. Laparoscopic fundoplication for dysphagia and peptic esophageal stricture. J Gastrointest Surg 1998;2:555-560.
5. Farrell TM, Smith CD, Metreveli RE, et al. Fundoplication provides effective and durable symptom relief in patients with Barrett's esophagus. Am J Surg 1999;178:18-21.
6. Campos GM, Peters JH, DeMeester TR, et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999;3:292-300.
7. Patti MG, Arcerito M, Feo CV, et al. Barrett's esophagus: a surgical disease. J Gastrointest Surg 1999;3:397-404.
8. Bonavina L, Ceriani C, Carazzone A, et al. Endoscopic laser ablation of nondysplastic Barrett's epithelium: is it worthwhile? J Gastrointest Surg 1999;3:194-199.
9. Soper NJ, Dunnegan D. Anatomic fundoplication failure after laparoscopic antireflux surgery. Ann Surg 1999;229:669-676.
10. Soot SJ, Eshraghi N, Farahmand M, et al. Transition from open to laparoscopic fundoplication: the learning curve. Arch Surg 1999;134:278-281.
11. Morgan S, Pohl D, Bogetti D, et al. Failed antireflux surgery: what have we learned from reoperations? Arch Surg 1999;134: 809-815.
12. Floch NR, Hinder RA, Klingler PJ, et al. Is laparoscopic reoperation for failed antireflux surgery feasible? Arch Surg 1999; 134:733-737.
13. Curet MJ, Josloff RK, Schoeb O, Zucker KA. Laparoscopic reoperation for failed antireflux procedures. Arch Surg 1999; 134:559-563.
14. Horgan S, Eubanks TR, Jacobsen G, et al. Repair of paraesophageal hernias. Am J Surg 1999;177:354-358.
15. Swanstrom LL, Jobe BA, Kinzie LR, Horvath KD. Esophageal motility and outcomes following laparoscopic paraesophageal hernia repair and fundoplication. Am J Surg 1999;177:359-363.
16. Hashemi M, Peters JH, DeMeester TR, et al. Laparoscopic repair of large type III hiatal hernias: objective follow-up reveals high recurrence rates. Presented at the 85th Clinical Congress, American College of Surgeons, San Francisco, CA, October 10-15, 1999.
17. Shiino Y, Filipi CJ, Awad ZT, et al. Surgery for achalasia: 1998. J Gastrointest Surg 1999;3:447-455.
18. Nigro JJ, Hagen JA, DeMeester TR, et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 1999;230:433-438.
19. Lau JY, Sung JJ, Lam YH, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 1999; 340:751-756.
20. Simeone DM, Hassan A, Scheiman JM. Giant peptic ulcer: a surgical or medical disease? Surgery 1999;126:474-478.
21. Feliciano DV, Ojukwu JC, Rozycki GS, et al. The epidemic of cocaine-related juxtapyloric perforations: with a comment on the importance of testing for Helicobacter pylori. Ann Surg 1999;229:801-804.
22. Katkhouda N, Mavor E, Mason RJ, et al. Laparoscopic repair of perforated duodenal ulcers: outcome and efficacy in 30 consecutive patients. Arch Surg 1999;134:845-848.
23. Forstner-Barthell AW, Murr MM, Nitecki S, et al. Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg 1999;3:15-23.
24. Oyogoa S, Schein M, Gardezi S, Wise L. Surgical feeding gastrostomy: are we overdoing it? J Gastrointest Surg 1999;3:152-155.
25. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymphnode dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999;340:908-914.
26. Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999;230:170-178.
27. Hansson LE, Sparen P, Nyren O. Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg 1999;230:162-169.
28. Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-1105.
29. Totte E, Hendrickx L, van Hee R. Biliopancreatic diversion for treatment of morbid obesity: experience in 180 consecutive cases. Obes Surg 1999;9:161-165.
30. Man K, Fan ST, Ng IO, et al. Tolerance of the liver to intermittent Pringle maneuver in hepatectomy for liver tumors. Arch Surg 1999;134:533-539.
31. Belghiti J, Noun R, Malafosse R, et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999;229:369-375.
32. Herline AJ, Stefansic JD, Debelak JP, et al. Image-guided surgery: preliminary feasibility studies of frameless stereotactic liver surgery. Arch Surg 1999;134:644-649.
33. Katkhouda N, Hurwitz M, Gugenheim J, et al. Laparoscopic management of benign solid and cystic lesions of the liver. Ann Surg 1999;229:460-466.
34. Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver re-section for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999;134:984-992.
35. Fan ST, Lo CM, Liu CL, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999;229: 322-330.
36. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790-799.
37. Farges O, Malassagne B, Flejou JF, et al. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 1999;229:210-215.
38. Nagasue N, Kohno H, Tachibana M, et al. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann Surg 1999; 229:84-90.
39. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230: 309-318.
40. Rahusen FD, Cuesta MA, Borgstein PJ, et al. Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg 1999;230:31-37.
41. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8.
42. Jiao LR, Hansen PD, Havlik R, et al. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg 1999;177:303-306.
43. Rose DM, Chapman WC, Brockenbrough AT, et al. Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg 1999;177:405-410.
44. Jenkins RL, Gedaly R, Pomposelli JJ, et al. Distal splenorenal shunt: role, indications, and utility in the era of liver transplantation. Arch Surg 1999;134:416-420.
45. Willsher PC, Sanabria JR, Gallinger S, et al. Early laparoscopic cholecystectomy for acute cholecystitis: a safe procedure. J Gastrointest Surg 1999;3:50-53.
46. Friel CM, Stack J, Forse A, Babineau TJ. Laparoscopic cholecystectomy in patients with hepatic cirrhosis: a five-year experience. J Gastrointest Surg 1999;3:286-291.
47. Barone JE, Bears S, Chen S, et al. Outcome study of cholecystectomy during pregnancy. Am J Surg 1999;177:232-236.
48. Lillemoe KD, Lin JW, Talamini MA, et al. Laparoscopic cholecystectomy as a "true" outpatient procedure: initial experience in 130 consecutive patients. J Gastrointest Surg 1999;3:44-49.
49. Higgins A, London J, Charland S, et al. Prophylactic antibiotics for elective laparoscopic cholecystectomy: are they necessary? Arch Surg 1999;134:611-613.
50. Bergamaschi R, Tuech JJ, Braconier L, et al. Selective endoscopic retrograde cholangiography prior to laparoscopic cholecystectomy for gallstones. Am J Surg 1999;178:46-49.
51. Giurgiu DI, Margulies DR, Carroll BJ, et al. Laparoscopic common bile duct exploration: long-term outcome. Arch Surg 1999; 134:839-843.
52. Murr MM, Gigot JF, Nagorney DM, et al. Long-term results of biliary reconstruction after laparoscopic bile duct injuries. Arch Surg 1999;134:604-609.
53. Launois B, Terblanche J, Lakehal M, et al. Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg 1999;230:266-275.
54. Taoka H, Hauptmann E, Traverso LW, et al. How accurate is helical computed tomography for clinical staging of pancreatic cancer? Am J Surg 1999;177:428-432.
55. Georgopoulos SK, Schwanz LH, Jarnagin WR, et al. Comparison of magnetic resonance and endoscopic retrograde cholangiopancreatography in malignant pancreaticobiliary obstruction. Arch Surg 1999;134:1002-1007.
56. Sugiyama M, Hagi H, Atomi Y. Reappraisal of intraoperative ultrasonography for pancreatobiliary carcinomas: assessment of malignant portal venous invasion. Surgery 1999;125:160-165.
57. Rose DM, Delbeke D, Beauchamp RD, et al. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 1999;229:729-737.
58. Povoski SP, Karpeh MS Jr, Conlon KC, et al. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 1999;230:131-142.
59. Bold RJ, Charnsangavej C, Cleary KR, et al. Major vascular resection as part of pancreaticoduodenectomy for cancer: radio-logic, intraoperative, and pathologic analysis. J Gastrointest Surg 1999;3:233-243.
60. Birkmeyer JD, Finlayson SR, Tosteson AN, et al. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery 1999;125:250-256.
61. Birkmeyer JD, Warshaw AL, Finlayson SR, et al. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 1999;126:178-183.
62. Luque-de Leon E, Tsiotos GG, Balsiger B, et al. Staging laparoscopy for pancreatic cancer should be used to select the best means of palliation and not only to maximize the resectability rate. J Gastrointest Surg 1999;3:111-118.
63. Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999;230: 322-328.
64. Espat NJ, Brennan MF, Conlon KC. Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg 1999;188:649-655.
65. Le Borgne J, de Calan L, Partensky C. Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 1999;230:152-161.
66. Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999;341:635-644.
67. Heider R, Meyer AA, Galanko JA, Behrns KE. Percutaneous drainage of pancreatic pseudocysts is associated with a higher failure rate than surgical treatment in unselected patients. Ann Surg 1999;229:781-787.
68. Shebani KO, Souba WW, Finkelstein DM, et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg 1999;229:815-821.
69. Peck JJ, Milleson T, Phelan J. The role of computed tomography with contrast and small bowel follow-through in management of small bowel obstruction. Am J Surg 1999;177:375-378.
70. Rao PM, Rhea JT, Rattner DW, et al. Introduction of appendiceal CT: impact on negative appendectomy and appendiceal perforation rates. Ann Surg 1999;229:344-349.
71. Barron B, Hanna C, Passalaqua AM, et al. Rapid diagnostic imaging of acute, nonclassic appendicitis by leukoscintigraphy with sulesomab, a technetium 99m-labeled antigranulocyte antibody Fab′ fragment. LeukoScan Appendicitis Clinical Trial Group. Surgery 1999;125:288-296.
72. Nguyen DB, Silen W, Hodin RA. Appendectomy in the pre - and postlaparoscopic eras. J Gastrointest Surg 1999;3:67-73.
73. Chung RS, Rowland DY, Li P, Diaz J. A meta-analysis of randomized controlled trials of laparoscopic versus conventional appendectomy. Am J Surg 1999;177:250-256.
74. Johansson B, Hallerback B, Glise H, et al. Laparoscopic mesh versus open preperitoneal mesh versus conventional technique for inguinal hernia repair: a randomized multicenter trial (SCUR Hernia Repair Study). Ann Surg 1999;230:225-231.
75. Solorzano CC, Minter RM, Childers TC, et al. Prospective evaluation of the giant prosthetic reinforcement of the visceral sac for recurrent and complex bilateral inguinal hernias. Am J Surg 1999;177:19-22.
76. Sanders LM, Flint LM, Ferrara JJ. Initial experience with laparoscopic repair of incisional hernias. Am J Surg 1999;177:227-231.
77. Omote K, Feussner H, Ungeheuer A, et al. Self-guided robotic-camera control for laparoscopic surgery compared with human camera control. Am J Surg 1999;177:321-324.
78. MacFarlane M, Rosen J, Hannaford B, et al. Force-feedback grasper helps restore sense of touch in minimally invasive surgery. J Gastrointest Surg 1999;3:278-285.
79. Pearlstone DB, Mansfield PF, Curley SA, et al. Laparoscopy in 533 patients with abdominal malignancy. Surgery 1999;125: 67-72.
80. Handoscopic surgery: a prospective multicenter trial of a minimally invasive technique for complex abdominal surgery. Southern Surgeons' Club Study Group. Arch Surg 1999;134:477-485.
81. Dellinger EP, Babineau TJ, Bleicher P, et al. Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Arch Surg 1999;134:977-983.
82. Khuri SF, Daley J, Henderson W, et al. Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program. Ann Surg 1999;230:414-429.
83. Gibbs J, Cull W, Henderson W, et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999;134:36-42.
84. Maker AV, Slezak LA, Aspelund G, et al. Impaired phosphorylation of hepatic insulin receptor and glucose transporter proteins in chronic pancreatitis. Surg Forum 1999;L:14-16.
85. Kim RD, McDade TP, Bankey PE, et al. Hypoosmotic stress activates nuclear factor-κB in primary rat hepatocytes: implications in cell cycle progression. Surg Forum 1999;L:21-23.
86. Pawlik TM, Rubin AI, Souba WW, Bode BP. Liver tumor cell nutrient uptake as a function of the cell cycle. Surg Forum 1999; L:23-25.
87. Maa J, Grady EF, Yoshimi SK, et al. Genetic deletion of the neurokinin-1 receptor improves survival in diet-induced hemorrhagic pancreatitis in mice. Surg Forum 1999;L:34-35.
88. Li M, Crisera CA, Maldonado TS, et al. Laminin-1 is a critical determinant of endocrine versus exocrine lineage selection in the embryonic pancreas. Surg Forum 1999;L:35-36.
89. Turner DJ, Cowles RA, Segura BJ, et al. Neuronal induction of c-fos transcription in pancreatic acinar cells occurs through muscarinic type 1 and 3 receptor subtypes. Surg Forum 1999;L:41-42.
90. Shen KR, Ashley SW, Jasleen J, et al. Glucagon-like peptide 2 stimulates intestinal epithelial proliferation by decreasing intra-cellular cyclic AMP concentration. Surg Forum 1999;L:50-52.
91. Wong VL, Levine AD. Regulation of intestinal immune tolerance and protection is mediated by signaling through the CD2 receptor on lamina propria T cells. Surg Forum 1999; L:54-56.
92. Schwarz NT, Kalff JC, Billiar TR, et al. Cyclooxygenase-2 mediates a significant component of postoperative ileus. Surg Forum 1999;L:56-58.